Allmed Solution(IL:ALMD)
ILAÂ 29.40-0.70 (-2.33%)
IL:ALMD
Allmed Solution financials statements
ILAÂ 29.40
At close:-0.70 (-2.33%)
Allmed Solution (ALMD) Ratios
1 Followers
Allmed Solution Ratios
IL:ALMD's free cash flow for Q2 2026 was ₪-5.69M. For the 2026 fiscal year, IL:ALMD's free cash flow was decreased by ₪-22.00K and operating cash flow was ₪-5.67M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 10.31 | 17.24 | 21.79 | 7.78 | 7.05 |
| Quick Ratio | 10.31 | 17.24 | 21.79 | 7.78 | 7.05 |
| Cash Ratio | 1.41 | 1.54 | 2.52 | 6.59 | 6.87 |
| Solvency Ratio | -3.90 | -0.00 | 0.49 | -2.79 | 1.56 |
| Operating Cash Flow Ratio | -4.10 | -3.16 | 2.69 | -3.20 | -2.41 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | -18.50 |
| Net Current Asset Value | ₪ 26.92M | ₪ 41.02M | ₪ 54.64M | ₪ 21.01M | ₪ 13.53M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.03 | 0.01 | 0.01 | 0.01 | 0.01 |
| Debt-to-Equity Ratio | 0.04 | 0.02 | 0.02 | 0.01 | 0.01 |
| Debt-to-Capital Ratio | 0.03 | 0.02 | 0.02 | 0.01 | 0.01 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.25 | 1.14 | 1.11 | 1.12 | 1.09 |
| Debt Service Coverage Ratio | -200580.65 | -0.18 | -133.74 | -191.98 | 7.88 |
| Interest Coverage Ratio | -209951.61 | -0.18 | -41.80 | -267.30 | 32.16 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Interest Debt Per Share | 0.09 | 0.01 | 0.01 | 0.01 | 0.01 |
| Net Debt to EBITDA | 0.26 | 303.16 | 0.54 | 2.31 | -3.95 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 55.60% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 50.48% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 69.63% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 112.52% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 48.75% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 50.64% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 48.75% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 92.20% | 103.88% |
| EBT Per EBIT | 108.50% | 79.07% | -42.52% | 98.73% | 43.32% |
| Return on Assets (ROA) | -44.78% | -0.02% | 2.40% | -19.37% | 5.12% |
| Return on Equity (ROE) | -55.95% | -0.02% | 2.66% | -21.73% | 5.57% |
| Return on Capital Employed (ROCE) | -45.52% | -0.03% | -5.92% | -22.53% | 11.88% |
| Return on Invested Capital (ROIC) | -44.96% | -0.03% | -5.88% | -22.45% | 11.75% |
| Return on Tangible Assets | -44.78% | -0.02% | 2.41% | -19.41% | 5.14% |
| Earnings Yield | -440.00% | -0.03% | 4.66% | -51.38% | 7.95% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 15.75 |
| Payables Turnover | 0.23 | 0.99 | 0.72 | 0.75 | 10.75 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 12.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.10 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.22 |
| Cash Conversion Cycle | -1591.81 | -368.27 | -509.16 | -489.76 | -10.78 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 23.17 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 1591.81 | 368.27 | 509.16 | 489.76 | 33.95 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 23.17 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -1.21 | -0.09 | 0.09 | -0.13 | -0.07 |
| Free Cash Flow Per Share | -1.21 | -0.10 | 0.09 | -0.13 | -0.07 |
| Dividend Paid and CapEx Coverage Ratio | -280.98 | -68.01 | 59.97 | -23.32 | -124.48 |
| Capital Expenditure Coverage Ratio | -280.98 | -68.01 | 59.97 | -23.32 | -124.48 |
| Operating Cash Flow Coverage Ratio | -13.64 | -12.96 | 8.16 | -15.29 | -15.43 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | -0.99 |
| Free Cash Flow Yield | -377.73% | -28.00% | 23.01% | -48.90% | -15.64% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.23 | -3322.85 | 21.45 | -1.95 | 12.57 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 6.37 |
| Price-to-Book (P/B) Ratio | 0.13 | 0.74 | 0.57 | 0.42 | 0.70 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.26 | -3.57 | 4.35 | -2.05 | -6.40 |
| Price-to-Operating Cash Flow Ratio | -0.27 | -3.62 | 4.27 | -2.13 | -6.45 |
| Price-to-Earnings Growth (PEG) Ratio | -0.00 | 3.85 | -0.20 | 0.00 | -0.10 |
| Enterprise Value Multiple | 0.00 | -2374.95 | -2.31 | -0.16 | 5.20 |
| Enterprise Value | -46.03K | 25.79M | 24.70M | 1.42M | 20.06M |
| EV to EBITDA | 0.00 | -2374.95 | -2.31 | -0.16 | 5.20 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 3.62 |
| EV to Free Cash Flow | 0.00 | -3.17 | 3.52 | -0.13 | -3.63 |
| EV to Operating Cash Flow | 0.00 | -3.21 | 3.46 | -0.14 | -3.66 |
| Tangible Book Value Per Share | 2.81 | 0.49 | 0.69 | 0.67 | 0.65 |
| Shareholders’ Equity Per Share | 2.52 | 0.46 | 0.66 | 0.64 | 0.63 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.07 |
| Net Income Per Share | -1.41 | -0.00 | 0.02 | -0.14 | 0.03 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 0.92 | 1.04 |
| Interest Burden | 1.09 | 0.79 | -0.13 | 1.29 | 0.97 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.98 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.41 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.39 |
| Income Quality | 0.86 | 0.92 | 5.02 | 0.84 | -2.03 |
Currency in ILS

